Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02506244 · ClinicalTrials.gov registry record · NA
mHealth Screening to Prevent Strokes
A NA study, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- NA
- Development phase
- 6,135
- Enrollment target
NCT02506244 is a NA study that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 6,135 participants.
The verdict
NCT02506244, a NA study, has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,135 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previously undiagnosed atrial fibrillation, and provide clinical evidence of an outcomes benefit associated with this early detection.
Interventions
- DEVICE iRhythm ZIO XT Patch
- DEVICE Wristband by Amiigo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,135 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02506244
The ClinicalTrials.gov registry entry for NCT02506244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iRhythm ZIO XT Patch is the first listed.
NCT02506244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02506244 about?
NCT02506244 is a clinical study titled "mHealth Screening to Prevent Strokes". The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previo...
What is the current status of trial NCT02506244?
This trial is currently completed. It is a NA study. The enrollment target is 6,135 participants. The study started on 2015-11. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02506244?
The interventions under investigation include: iRhythm ZIO XT Patch (DEVICE), Wristband by Amiigo (DEVICE).
Who is sponsoring clinical trial NCT02506244?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.